Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis

BACKGROUND: Osteoporosis compromises bone strength and increases the risk of fractures. Zoledronate prevents loss of bone mass and reduces the risk of fractures. OBJECTIVES: To determine the efficacy and safety of zoledronate in postmenopausal women with osteopenia and osteoporosis. DESIGN AND SETTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazoni, Fernanda Martins, Civile, Vinicius Tassoni, Atallah, Álvaro Nagib, Santos, Fânia Cristina, Trevisani, Virginia Fernandes Moça
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214983/
https://www.ncbi.nlm.nih.gov/pubmed/37255065
http://dx.doi.org/10.1590/1516-3180.2022.0480.R1.27032023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214983/
https://www.ncbi.nlm.nih.gov/pubmed/37255065
http://dx.doi.org/10.1590/1516-3180.2022.0480.R1.27032023

Ejemplares similares